Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 117 | 2024 | 825 | 20.150 |
Why?
|
Diet, Gluten-Free | 62 | 2024 | 283 | 9.660 |
Why?
|
Glutens | 32 | 2021 | 240 | 5.690 |
Why?
|
Colonoscopy | 17 | 2019 | 1394 | 2.470 |
Why?
|
Transglutaminases | 19 | 2021 | 197 | 2.030 |
Why?
|
Serologic Tests | 10 | 2019 | 384 | 1.710 |
Why?
|
Gastroenterology | 15 | 2022 | 577 | 1.600 |
Why?
|
Enterocolitis, Pseudomembranous | 7 | 2015 | 264 | 1.420 |
Why?
|
Gastrointestinal Agents | 6 | 2019 | 510 | 1.320 |
Why?
|
Patient Compliance | 16 | 2022 | 2690 | 1.280 |
Why?
|
Gliadin | 13 | 2021 | 80 | 1.170 |
Why?
|
Duodenum | 12 | 2023 | 489 | 1.150 |
Why?
|
Conscious Sedation | 3 | 2016 | 532 | 1.100 |
Why?
|
Endoscopy, Gastrointestinal | 13 | 2020 | 873 | 1.060 |
Why?
|
Gastrointestinal Hemorrhage | 5 | 2016 | 1116 | 1.020 |
Why?
|
Clostridium Infections | 7 | 2017 | 558 | 1.010 |
Why?
|
Intestinal Mucosa | 15 | 2023 | 3027 | 0.960 |
Why?
|
Adenoma | 8 | 2018 | 2159 | 0.940 |
Why?
|
Immunoglobulin A | 16 | 2023 | 980 | 0.880 |
Why?
|
Methemoglobinemia | 2 | 2013 | 44 | 0.870 |
Why?
|
Oligopeptides | 6 | 2018 | 1186 | 0.870 |
Why?
|
Autoantibodies | 15 | 2023 | 2123 | 0.840 |
Why?
|
Cost of Illness | 6 | 2020 | 1935 | 0.830 |
Why?
|
Gastric Juice | 1 | 2021 | 59 | 0.760 |
Why?
|
Anesthesia, Local | 2 | 2013 | 277 | 0.740 |
Why?
|
Capsule Endoscopy | 2 | 2023 | 100 | 0.710 |
Why?
|
HLA-DQ Antigens | 6 | 2020 | 211 | 0.690 |
Why?
|
Endopeptidases | 2 | 2021 | 773 | 0.660 |
Why?
|
Food Hypersensitivity | 5 | 2021 | 707 | 0.650 |
Why?
|
Biopsy | 20 | 2024 | 6768 | 0.640 |
Why?
|
Colonic Polyps | 4 | 2019 | 554 | 0.630 |
Why?
|
Humans | 199 | 2024 | 761326 | 0.620 |
Why?
|
Antidotes | 2 | 2016 | 137 | 0.600 |
Why?
|
Irritable Bowel Syndrome | 6 | 2017 | 455 | 0.600 |
Why?
|
Drug Evaluation | 2 | 2016 | 642 | 0.580 |
Why?
|
Midazolam | 2 | 2016 | 266 | 0.580 |
Why?
|
GTP-Binding Proteins | 9 | 2020 | 950 | 0.540 |
Why?
|
Anesthetics, Local | 2 | 2013 | 997 | 0.540 |
Why?
|
Gastrointestinal Diseases | 6 | 2017 | 1198 | 0.540 |
Why?
|
Mesalamine | 2 | 2014 | 135 | 0.530 |
Why?
|
Colorectal Neoplasms | 8 | 2019 | 6901 | 0.520 |
Why?
|
Anti-Bacterial Agents | 10 | 2018 | 7439 | 0.520 |
Why?
|
Hypersensitivity | 2 | 2015 | 1158 | 0.520 |
Why?
|
Fentanyl | 2 | 2016 | 435 | 0.520 |
Why?
|
Quality of Life | 8 | 2024 | 13355 | 0.520 |
Why?
|
Male | 113 | 2024 | 360621 | 0.510 |
Why?
|
Health Status | 4 | 2020 | 4075 | 0.510 |
Why?
|
Middle Aged | 87 | 2024 | 220774 | 0.500 |
Why?
|
Capnography | 1 | 2016 | 91 | 0.500 |
Why?
|
Diarrhea | 6 | 2022 | 1319 | 0.500 |
Why?
|
Female | 115 | 2024 | 392485 | 0.500 |
Why?
|
Anti-Inflammatory Agents | 4 | 2020 | 1809 | 0.490 |
Why?
|
Adult | 85 | 2024 | 221122 | 0.480 |
Why?
|
Health Resources | 1 | 2020 | 935 | 0.460 |
Why?
|
Radionuclide Imaging | 2 | 2016 | 1975 | 0.460 |
Why?
|
Colonic Diseases | 1 | 2016 | 201 | 0.460 |
Why?
|
Colitis, Ulcerative | 4 | 2020 | 1922 | 0.450 |
Why?
|
Eosinophils | 2 | 2018 | 947 | 0.450 |
Why?
|
Triticum | 2 | 2012 | 90 | 0.450 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 416 | 0.450 |
Why?
|
Osteoporosis | 3 | 2022 | 1605 | 0.440 |
Why?
|
Hypnotics and Sedatives | 3 | 2016 | 1178 | 0.440 |
Why?
|
Eosinophilia | 1 | 2018 | 560 | 0.440 |
Why?
|
Deep Sedation | 1 | 2014 | 118 | 0.430 |
Why?
|
Budesonide | 4 | 2020 | 157 | 0.420 |
Why?
|
Alanine Transaminase | 1 | 2015 | 605 | 0.410 |
Why?
|
Inflammatory Bowel Diseases | 9 | 2022 | 2421 | 0.410 |
Why?
|
Ambulatory Care | 3 | 2020 | 2775 | 0.410 |
Why?
|
Severity of Illness Index | 13 | 2020 | 15835 | 0.380 |
Why?
|
Probiotics | 3 | 2016 | 377 | 0.370 |
Why?
|
Hospitalization | 6 | 2020 | 10715 | 0.370 |
Why?
|
Quality Improvement | 4 | 2019 | 3800 | 0.370 |
Why?
|
Narcotic Antagonists | 1 | 2016 | 585 | 0.370 |
Why?
|
Emergency Service, Hospital | 6 | 2020 | 7872 | 0.370 |
Why?
|
Congresses as Topic | 1 | 2015 | 803 | 0.360 |
Why?
|
Health Care Costs | 2 | 2020 | 3243 | 0.350 |
Why?
|
Withholding Treatment | 1 | 2014 | 617 | 0.350 |
Why?
|
Morbidity | 1 | 2015 | 1750 | 0.350 |
Why?
|
Guideline Adherence | 6 | 2016 | 2221 | 0.350 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2017 | 2273 | 0.350 |
Why?
|
Education, Medical, Undergraduate | 5 | 2017 | 1066 | 0.340 |
Why?
|
Young Adult | 36 | 2024 | 59196 | 0.330 |
Why?
|
Food Services | 1 | 2012 | 207 | 0.330 |
Why?
|
Ischemic Attack, Transient | 1 | 2014 | 879 | 0.330 |
Why?
|
Drug Approval | 1 | 2016 | 814 | 0.330 |
Why?
|
Drug Discovery | 2 | 2016 | 1054 | 0.320 |
Why?
|
Abdominal Pain | 2 | 2019 | 1071 | 0.320 |
Why?
|
Autoimmunity | 1 | 2016 | 1355 | 0.310 |
Why?
|
Practice Guidelines as Topic | 9 | 2016 | 7389 | 0.310 |
Why?
|
Aged | 57 | 2024 | 169179 | 0.300 |
Why?
|
Perception | 1 | 2014 | 1197 | 0.290 |
Why?
|
Teaching | 3 | 2017 | 1169 | 0.290 |
Why?
|
Reminder Systems | 1 | 2011 | 388 | 0.290 |
Why?
|
Medical Records | 5 | 2017 | 1408 | 0.290 |
Why?
|
Gastroesophageal Reflux | 2 | 2014 | 816 | 0.290 |
Why?
|
Universities | 1 | 2012 | 994 | 0.290 |
Why?
|
Gastroparesis | 1 | 2009 | 136 | 0.280 |
Why?
|
Gastric Emptying | 1 | 2009 | 242 | 0.280 |
Why?
|
Aged, 80 and over | 27 | 2019 | 58946 | 0.270 |
Why?
|
Case-Control Studies | 12 | 2024 | 22124 | 0.260 |
Why?
|
Colitis, Microscopic | 1 | 2007 | 72 | 0.260 |
Why?
|
Quality Indicators, Health Care | 4 | 2018 | 1792 | 0.260 |
Why?
|
Salivary Proline-Rich Proteins | 2 | 2015 | 5 | 0.260 |
Why?
|
Socioeconomic Factors | 4 | 2019 | 7824 | 0.260 |
Why?
|
Risk Factors | 26 | 2024 | 74152 | 0.260 |
Why?
|
Retrospective Studies | 29 | 2023 | 80575 | 0.250 |
Why?
|
Patient Satisfaction | 2 | 2016 | 3460 | 0.250 |
Why?
|
Nutritional Status | 1 | 2014 | 1613 | 0.250 |
Why?
|
Mortality | 2 | 2019 | 2898 | 0.250 |
Why?
|
Testosterone | 1 | 2016 | 2472 | 0.250 |
Why?
|
Venous Thrombosis | 1 | 2014 | 1303 | 0.250 |
Why?
|
Anemia | 3 | 2022 | 1508 | 0.240 |
Why?
|
Genetic Testing | 2 | 2015 | 3538 | 0.240 |
Why?
|
Hospital Costs | 1 | 2010 | 948 | 0.230 |
Why?
|
Amoxicillin | 2 | 2016 | 180 | 0.230 |
Why?
|
Esophageal Diseases | 2 | 2015 | 169 | 0.230 |
Why?
|
Treatment Outcome | 17 | 2020 | 64645 | 0.230 |
Why?
|
Conflict of Interest | 5 | 2016 | 554 | 0.230 |
Why?
|
Proton Pump Inhibitors | 3 | 2017 | 531 | 0.230 |
Why?
|
Atrophy | 7 | 2023 | 1632 | 0.230 |
Why?
|
Colonic Neoplasms | 2 | 2018 | 2534 | 0.230 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2011 | 953 | 0.220 |
Why?
|
Predictive Value of Tests | 13 | 2018 | 15262 | 0.220 |
Why?
|
Feces | 5 | 2020 | 1495 | 0.220 |
Why?
|
Research Support as Topic | 3 | 2021 | 697 | 0.220 |
Why?
|
Cross Infection | 3 | 2017 | 1438 | 0.210 |
Why?
|
Evidence-Based Medicine | 5 | 2016 | 3687 | 0.210 |
Why?
|
Bronchial Diseases | 2 | 2014 | 150 | 0.210 |
Why?
|
Follow-Up Studies | 14 | 2023 | 39108 | 0.210 |
Why?
|
Informed Consent | 2 | 2019 | 1008 | 0.210 |
Why?
|
Outpatients | 1 | 2010 | 1596 | 0.200 |
Why?
|
Medication Adherence | 1 | 2014 | 2176 | 0.200 |
Why?
|
Focus Groups | 3 | 2014 | 1414 | 0.200 |
Why?
|
Time Factors | 13 | 2018 | 39974 | 0.200 |
Why?
|
Pulmonary Medicine | 2 | 2014 | 221 | 0.190 |
Why?
|
Mendelian Randomization Analysis | 2 | 2024 | 1005 | 0.190 |
Why?
|
Random Allocation | 2 | 2021 | 2389 | 0.190 |
Why?
|
Endoscopy, Digestive System | 2 | 2015 | 351 | 0.190 |
Why?
|
Fellowships and Scholarships | 3 | 2019 | 1117 | 0.190 |
Why?
|
Histamine H2 Antagonists | 2 | 2017 | 166 | 0.190 |
Why?
|
Pulmonary Embolism | 1 | 2014 | 2566 | 0.190 |
Why?
|
Data Collection | 2 | 2017 | 3324 | 0.180 |
Why?
|
Dietetics | 1 | 2020 | 34 | 0.180 |
Why?
|
Education, Medical, Continuing | 3 | 2015 | 824 | 0.180 |
Why?
|
Women's Health | 1 | 2010 | 2065 | 0.180 |
Why?
|
Qualitative Research | 2 | 2024 | 3025 | 0.180 |
Why?
|
Quality of Health Care | 1 | 2015 | 4330 | 0.180 |
Why?
|
Career Choice | 1 | 2017 | 756 | 0.180 |
Why?
|
Cost-Benefit Analysis | 5 | 2020 | 5492 | 0.180 |
Why?
|
Nephrology | 2 | 2014 | 263 | 0.180 |
Why?
|
Immunologic Tests | 1 | 2020 | 103 | 0.170 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3806 | 0.170 |
Why?
|
Anticoagulants | 2 | 2015 | 4813 | 0.170 |
Why?
|
Early Detection of Cancer | 4 | 2019 | 3200 | 0.170 |
Why?
|
Norway | 1 | 2021 | 498 | 0.170 |
Why?
|
Staff Development | 2 | 2015 | 228 | 0.170 |
Why?
|
Documentation | 2 | 2017 | 897 | 0.170 |
Why?
|
Adolescent | 22 | 2024 | 88305 | 0.170 |
Why?
|
Prospective Studies | 18 | 2023 | 54405 | 0.170 |
Why?
|
Cohort Studies | 14 | 2024 | 41440 | 0.170 |
Why?
|
Recurrence | 7 | 2019 | 8470 | 0.160 |
Why?
|
Massachusetts | 5 | 2016 | 8837 | 0.160 |
Why?
|
Autoimmune Diseases | 3 | 2024 | 2248 | 0.160 |
Why?
|
Forecasting | 1 | 2008 | 2928 | 0.160 |
Why?
|
Diagnostic Techniques, Digestive System | 2 | 2016 | 46 | 0.160 |
Why?
|
Tropheryma | 1 | 2018 | 4 | 0.160 |
Why?
|
Gastrointestinal Tract | 3 | 2016 | 831 | 0.150 |
Why?
|
Nutrition Surveys | 2 | 2016 | 1728 | 0.150 |
Why?
|
Whipple Disease | 1 | 2018 | 20 | 0.150 |
Why?
|
Antibodies | 3 | 2017 | 2421 | 0.150 |
Why?
|
Body Mass Index | 2 | 2016 | 12949 | 0.150 |
Why?
|
Physicians | 4 | 2018 | 4591 | 0.150 |
Why?
|
o-Phthalaldehyde | 1 | 2017 | 15 | 0.150 |
Why?
|
Diet Therapy | 1 | 2018 | 150 | 0.150 |
Why?
|
Duodenoscopy | 1 | 2017 | 45 | 0.150 |
Why?
|
Ethylene Oxide | 1 | 2017 | 28 | 0.150 |
Why?
|
United States | 15 | 2021 | 72317 | 0.150 |
Why?
|
Age Factors | 5 | 2019 | 18401 | 0.150 |
Why?
|
Immunoglobulin G | 6 | 2017 | 4550 | 0.150 |
Why?
|
Equipment Reuse | 1 | 2017 | 45 | 0.140 |
Why?
|
Interviews as Topic | 2 | 2017 | 2696 | 0.140 |
Why?
|
Clavulanic Acid | 1 | 2016 | 19 | 0.140 |
Why?
|
Patient Education as Topic | 3 | 2019 | 2319 | 0.140 |
Why?
|
Protein Engineering | 1 | 2021 | 550 | 0.140 |
Why?
|
Duodenoscopes | 1 | 2017 | 43 | 0.140 |
Why?
|
Critical Illness | 1 | 2010 | 2722 | 0.140 |
Why?
|
Patient Care | 2 | 2013 | 621 | 0.140 |
Why?
|
Double-Blind Method | 6 | 2021 | 12329 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2024 | 12144 | 0.140 |
Why?
|
Ataxia | 1 | 2019 | 306 | 0.140 |
Why?
|
Sterilization | 1 | 2017 | 133 | 0.140 |
Why?
|
Feeding Behavior | 1 | 2009 | 3187 | 0.140 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2024 | 1374 | 0.130 |
Why?
|
Income | 2 | 2016 | 1876 | 0.130 |
Why?
|
Clinical Competence | 3 | 2017 | 4793 | 0.130 |
Why?
|
Dyspepsia | 1 | 2017 | 116 | 0.130 |
Why?
|
Prevalence | 9 | 2020 | 15719 | 0.130 |
Why?
|
Flumazenil | 1 | 2016 | 84 | 0.130 |
Why?
|
Tight Junctions | 3 | 2015 | 323 | 0.130 |
Why?
|
IgA Deficiency | 1 | 2016 | 43 | 0.130 |
Why?
|
Equipment Contamination | 1 | 2017 | 181 | 0.130 |
Why?
|
Disinfectants | 1 | 2017 | 129 | 0.130 |
Why?
|
Postoperative Hemorrhage | 1 | 2019 | 415 | 0.130 |
Why?
|
Lactulose | 2 | 2012 | 31 | 0.130 |
Why?
|
Enterotoxins | 2 | 2015 | 367 | 0.130 |
Why?
|
Logistic Models | 8 | 2024 | 13251 | 0.130 |
Why?
|
Atropine | 1 | 2016 | 244 | 0.130 |
Why?
|
Lactobacillus | 1 | 2017 | 212 | 0.130 |
Why?
|
Iohexol | 1 | 2016 | 204 | 0.130 |
Why?
|
Intestine, Large | 1 | 2015 | 68 | 0.120 |
Why?
|
North America | 2 | 2019 | 1275 | 0.120 |
Why?
|
Metronidazole | 1 | 2016 | 232 | 0.120 |
Why?
|
Salivary Proteins and Peptides | 1 | 2015 | 48 | 0.120 |
Why?
|
Disinfection | 1 | 2017 | 210 | 0.120 |
Why?
|
Biomedical Research | 3 | 2021 | 3429 | 0.120 |
Why?
|
Combined Modality Therapy | 3 | 2016 | 8526 | 0.120 |
Why?
|
Health Surveys | 2 | 2016 | 4059 | 0.120 |
Why?
|
Citrulline | 1 | 2015 | 106 | 0.120 |
Why?
|
Personality | 1 | 2018 | 554 | 0.120 |
Why?
|
Trametes | 1 | 2014 | 2 | 0.120 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3531 | 0.120 |
Why?
|
Injections | 1 | 2018 | 830 | 0.120 |
Why?
|
Psychometrics | 1 | 2024 | 3064 | 0.120 |
Why?
|
Malnutrition | 2 | 2012 | 644 | 0.120 |
Why?
|
Gastric Acid | 1 | 2014 | 98 | 0.120 |
Why?
|
Vancomycin Resistance | 1 | 2015 | 126 | 0.120 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2373 | 0.120 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2024 | 3441 | 0.120 |
Why?
|
Prebiotics | 1 | 2014 | 41 | 0.120 |
Why?
|
Central Nervous System Diseases | 1 | 2019 | 520 | 0.120 |
Why?
|
Off-Label Use | 1 | 2016 | 185 | 0.120 |
Why?
|
beta-Alanine | 1 | 2014 | 82 | 0.120 |
Why?
|
Crohn Disease | 2 | 2020 | 2279 | 0.120 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2016 | 296 | 0.120 |
Why?
|
Sex Factors | 3 | 2016 | 10551 | 0.120 |
Why?
|
Bradycardia | 1 | 2016 | 299 | 0.120 |
Why?
|
Stomach Diseases | 1 | 2015 | 134 | 0.110 |
Why?
|
Decision Support Techniques | 2 | 2014 | 1998 | 0.110 |
Why?
|
Private Practice | 3 | 2023 | 153 | 0.110 |
Why?
|
Risk Assessment | 8 | 2019 | 23981 | 0.110 |
Why?
|
Sensitivity and Specificity | 9 | 2019 | 14665 | 0.110 |
Why?
|
Salicylates | 1 | 2014 | 127 | 0.110 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2017 | 793 | 0.110 |
Why?
|
Liver Function Tests | 1 | 2015 | 522 | 0.110 |
Why?
|
Fertility | 2 | 2010 | 771 | 0.110 |
Why?
|
Acute Disease | 2 | 2016 | 7238 | 0.110 |
Why?
|
Benzocaine | 1 | 2013 | 13 | 0.110 |
Why?
|
Esophageal Stenosis | 1 | 2015 | 196 | 0.110 |
Why?
|
Vancomycin | 1 | 2016 | 503 | 0.110 |
Why?
|
Naloxone | 1 | 2016 | 370 | 0.110 |
Why?
|
Faculty, Medical | 2 | 2015 | 1202 | 0.110 |
Why?
|
Lymphocytosis | 1 | 2014 | 121 | 0.110 |
Why?
|
Trypsin Inhibitors | 1 | 2012 | 36 | 0.110 |
Why?
|
Folic Acid Deficiency | 1 | 2014 | 117 | 0.110 |
Why?
|
Therapeutic Irrigation | 1 | 2014 | 292 | 0.110 |
Why?
|
Students, Dental | 1 | 2015 | 173 | 0.110 |
Why?
|
Group Processes | 2 | 2012 | 226 | 0.110 |
Why?
|
False Negative Reactions | 1 | 2014 | 573 | 0.110 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2014 | 118 | 0.100 |
Why?
|
Methylene Blue | 1 | 2013 | 155 | 0.100 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2017 | 589 | 0.100 |
Why?
|
Food | 2 | 2015 | 772 | 0.100 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3419 | 0.100 |
Why?
|
Education, Dental | 1 | 2015 | 221 | 0.100 |
Why?
|
Comorbidity | 5 | 2024 | 10498 | 0.100 |
Why?
|
Stroke | 1 | 2014 | 9749 | 0.100 |
Why?
|
Saliva | 1 | 2017 | 827 | 0.100 |
Why?
|
Enoxaparin | 1 | 2014 | 391 | 0.100 |
Why?
|
Barrett Esophagus | 1 | 2016 | 490 | 0.100 |
Why?
|
Coronary Angiography | 2 | 2014 | 4472 | 0.100 |
Why?
|
Cooking | 1 | 2014 | 315 | 0.100 |
Why?
|
Eosinophilic Esophagitis | 1 | 2015 | 192 | 0.100 |
Why?
|
Disease Management | 2 | 2020 | 2504 | 0.100 |
Why?
|
Intubation, Gastrointestinal | 1 | 2013 | 166 | 0.100 |
Why?
|
Immune Tolerance | 1 | 2021 | 2300 | 0.100 |
Why?
|
Multimedia | 1 | 2012 | 75 | 0.100 |
Why?
|
Natural Language Processing | 2 | 2017 | 1162 | 0.100 |
Why?
|
Sickness Impact Profile | 1 | 2013 | 299 | 0.100 |
Why?
|
Bacterial Toxins | 2 | 2015 | 932 | 0.100 |
Why?
|
Mannitol | 1 | 2012 | 180 | 0.100 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2016 | 773 | 0.100 |
Why?
|
Morpholines | 1 | 2014 | 581 | 0.100 |
Why?
|
Obesity | 2 | 2022 | 12934 | 0.090 |
Why?
|
Genetic Markers | 2 | 2015 | 2612 | 0.090 |
Why?
|
Immunomodulation | 1 | 2015 | 547 | 0.090 |
Why?
|
Proteoglycans | 1 | 2014 | 803 | 0.090 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7045 | 0.090 |
Why?
|
Drug Design | 1 | 2016 | 1050 | 0.090 |
Why?
|
Analgesics | 1 | 2018 | 1070 | 0.090 |
Why?
|
Patient Readmission | 2 | 2015 | 3267 | 0.090 |
Why?
|
Boston | 4 | 2021 | 9333 | 0.090 |
Why?
|
Problem-Based Learning | 3 | 2012 | 353 | 0.090 |
Why?
|
Information Dissemination | 2 | 2017 | 1127 | 0.090 |
Why?
|
Immunization | 1 | 2015 | 1226 | 0.090 |
Why?
|
Employee Discipline | 1 | 1990 | 8 | 0.090 |
Why?
|
Intestinal Diseases | 1 | 2015 | 504 | 0.090 |
Why?
|
Professional Impairment | 1 | 1990 | 7 | 0.090 |
Why?
|
Fetal Blood | 1 | 2017 | 1347 | 0.090 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 1212 | 0.090 |
Why?
|
Students, Medical | 3 | 2015 | 1930 | 0.090 |
Why?
|
Plant Proteins | 1 | 2012 | 369 | 0.090 |
Why?
|
Thiophenes | 1 | 2014 | 569 | 0.090 |
Why?
|
Patient Preference | 1 | 2018 | 926 | 0.090 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2013 | 506 | 0.090 |
Why?
|
Prognosis | 8 | 2016 | 29588 | 0.090 |
Why?
|
Communication | 3 | 2014 | 3870 | 0.090 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2014 | 273 | 0.090 |
Why?
|
Program Evaluation | 4 | 2015 | 2494 | 0.090 |
Why?
|
Prescription Drugs | 1 | 2017 | 631 | 0.090 |
Why?
|
Area Under Curve | 1 | 2014 | 1633 | 0.090 |
Why?
|
Educational Status | 2 | 2015 | 2520 | 0.090 |
Why?
|
Clinical Laboratory Techniques | 1 | 2015 | 747 | 0.090 |
Why?
|
Hypotension | 1 | 2016 | 879 | 0.090 |
Why?
|
Iatrogenic Disease | 1 | 2013 | 539 | 0.090 |
Why?
|
Guidelines as Topic | 2 | 2016 | 1385 | 0.090 |
Why?
|
Europe | 3 | 2019 | 3420 | 0.080 |
Why?
|
Intention | 1 | 2012 | 347 | 0.080 |
Why?
|
Micronutrients | 2 | 2023 | 381 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2018 | 6086 | 0.080 |
Why?
|
Histocompatibility Testing | 2 | 2014 | 719 | 0.080 |
Why?
|
Immunosuppressive Agents | 2 | 2016 | 4173 | 0.080 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2014 | 369 | 0.080 |
Why?
|
Benzimidazoles | 1 | 2014 | 858 | 0.080 |
Why?
|
Monitoring, Intraoperative | 1 | 2016 | 941 | 0.080 |
Why?
|
Musculoskeletal Diseases | 1 | 2015 | 597 | 0.080 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4850 | 0.080 |
Why?
|
Nanoparticles | 1 | 2021 | 1955 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36430 | 0.080 |
Why?
|
Pyridones | 1 | 2014 | 808 | 0.080 |
Why?
|
Risk Management | 1 | 2013 | 558 | 0.080 |
Why?
|
Toll-Like Receptor 4 | 1 | 2012 | 579 | 0.080 |
Why?
|
Databases, Factual | 2 | 2016 | 7954 | 0.080 |
Why?
|
Fatigue | 1 | 2016 | 1551 | 0.080 |
Why?
|
Pathology | 1 | 2012 | 270 | 0.080 |
Why?
|
Parturition | 1 | 2012 | 445 | 0.080 |
Why?
|
Dehydration | 1 | 2010 | 216 | 0.080 |
Why?
|
Diet Surveys | 1 | 2012 | 1162 | 0.080 |
Why?
|
Leukocytes, Mononuclear | 1 | 2015 | 1842 | 0.080 |
Why?
|
Peptides | 1 | 2020 | 4342 | 0.080 |
Why?
|
Secondary Prevention | 2 | 2012 | 1474 | 0.080 |
Why?
|
Lymphocytes | 1 | 2016 | 2610 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2016 | 880 | 0.080 |
Why?
|
Thromboembolism | 1 | 2014 | 996 | 0.080 |
Why?
|
Triage | 1 | 2015 | 986 | 0.070 |
Why?
|
Propofol | 1 | 2013 | 603 | 0.070 |
Why?
|
Sweden | 2 | 2024 | 1379 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2020 | 10764 | 0.070 |
Why?
|
Incidence | 5 | 2018 | 21336 | 0.070 |
Why?
|
Lymphoma | 1 | 2017 | 1901 | 0.070 |
Why?
|
Heparin | 1 | 2014 | 1633 | 0.070 |
Why?
|
Curriculum | 3 | 2017 | 3741 | 0.070 |
Why?
|
Bronchoscopy | 1 | 2013 | 909 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2019 | 4014 | 0.070 |
Why?
|
International Classification of Diseases | 1 | 2013 | 909 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2017 | 4812 | 0.070 |
Why?
|
Liver Diseases | 1 | 2015 | 1296 | 0.070 |
Why?
|
Risk | 2 | 2011 | 9605 | 0.070 |
Why?
|
Echocardiography, Transesophageal | 1 | 2013 | 1088 | 0.070 |
Why?
|
Erythrocytes | 1 | 2016 | 2418 | 0.070 |
Why?
|
Academic Medical Centers | 4 | 2019 | 2760 | 0.070 |
Why?
|
Skin Diseases | 1 | 2015 | 1092 | 0.070 |
Why?
|
Appointments and Schedules | 1 | 2010 | 443 | 0.070 |
Why?
|
Bacteriological Techniques | 2 | 2018 | 279 | 0.070 |
Why?
|
Cultural Competency | 1 | 2009 | 300 | 0.070 |
Why?
|
Warfarin | 1 | 2014 | 1483 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2019 | 15647 | 0.070 |
Why?
|
Adaptation, Psychological | 1 | 2017 | 2630 | 0.070 |
Why?
|
Biopsy, Needle | 2 | 2011 | 1626 | 0.060 |
Why?
|
Education, Medical | 1 | 2017 | 1725 | 0.060 |
Why?
|
Bacteria | 1 | 2016 | 2216 | 0.060 |
Why?
|
Cultural Diversity | 1 | 2009 | 368 | 0.060 |
Why?
|
Algorithms | 5 | 2023 | 14025 | 0.060 |
Why?
|
Parenteral Nutrition | 1 | 2010 | 659 | 0.060 |
Why?
|
Patients | 1 | 2012 | 906 | 0.060 |
Why?
|
Bone Density | 2 | 2010 | 3551 | 0.060 |
Why?
|
Attitude to Health | 1 | 2014 | 2025 | 0.060 |
Why?
|
Aspirin | 1 | 2017 | 3134 | 0.060 |
Why?
|
Weight Loss | 1 | 2017 | 2683 | 0.060 |
Why?
|
Steroids | 1 | 2010 | 928 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 7999 | 0.060 |
Why?
|
Proportional Hazards Models | 5 | 2017 | 12450 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2015 | 1665 | 0.060 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2009 | 664 | 0.060 |
Why?
|
Reference Values | 1 | 2012 | 4921 | 0.060 |
Why?
|
Terminology as Topic | 1 | 2012 | 1535 | 0.060 |
Why?
|
Bulimia | 1 | 2007 | 400 | 0.060 |
Why?
|
Psychotropic Drugs | 1 | 1990 | 888 | 0.060 |
Why?
|
Vaccination | 1 | 2016 | 3381 | 0.060 |
Why?
|
Pyrazoles | 1 | 2014 | 2007 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 1385 | 0.060 |
Why?
|
Treatment Failure | 2 | 2007 | 2642 | 0.060 |
Why?
|
Child | 9 | 2023 | 80156 | 0.060 |
Why?
|
Societies, Medical | 4 | 2021 | 3905 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9639 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2023 | 14597 | 0.060 |
Why?
|
Diet, Protein-Restricted | 1 | 2003 | 73 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10191 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2011 | 1780 | 0.050 |
Why?
|
Patient Selection | 1 | 2015 | 4244 | 0.050 |
Why?
|
Population Surveillance | 1 | 2014 | 2603 | 0.050 |
Why?
|
Phenotype | 3 | 2019 | 16603 | 0.050 |
Why?
|
Phyllodes Tumor | 1 | 2003 | 53 | 0.050 |
Why?
|
Contrast Media | 1 | 2016 | 5310 | 0.050 |
Why?
|
Alleles | 1 | 2014 | 6909 | 0.050 |
Why?
|
Multivariate Analysis | 4 | 2019 | 12059 | 0.050 |
Why?
|
Motivation | 1 | 2012 | 2006 | 0.050 |
Why?
|
Diagnosis, Differential | 5 | 2019 | 12972 | 0.050 |
Why?
|
Self Report | 1 | 2014 | 3724 | 0.050 |
Why?
|
Cross-Sectional Studies | 4 | 2017 | 26108 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2024 | 17872 | 0.050 |
Why?
|
Histocytochemistry | 1 | 2023 | 698 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 6987 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20092 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2008 | 2927 | 0.050 |
Why?
|
Community-Acquired Infections | 1 | 2006 | 468 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 2015 | 3847 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2471 | 0.050 |
Why?
|
Models, Statistical | 1 | 2016 | 5078 | 0.050 |
Why?
|
Weight Gain | 1 | 2012 | 2346 | 0.050 |
Why?
|
Probability | 1 | 2007 | 2478 | 0.050 |
Why?
|
Inpatients | 1 | 2013 | 2548 | 0.050 |
Why?
|
Glycolates | 1 | 2021 | 40 | 0.050 |
Why?
|
Lymphoma, T-Cell | 1 | 2003 | 304 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20555 | 0.050 |
Why?
|
Virus Activation | 1 | 2003 | 322 | 0.050 |
Why?
|
Workload | 1 | 2017 | 844 | 0.050 |
Why?
|
Registries | 3 | 2017 | 8223 | 0.050 |
Why?
|
Immunotherapy | 1 | 2016 | 4649 | 0.040 |
Why?
|
Internet | 1 | 2012 | 3094 | 0.040 |
Why?
|
Nurses | 1 | 1990 | 2478 | 0.040 |
Why?
|
Saccharomyces | 1 | 2020 | 63 | 0.040 |
Why?
|
Educational Measurement | 3 | 2015 | 1254 | 0.040 |
Why?
|
Tablets, Enteric-Coated | 1 | 2019 | 20 | 0.040 |
Why?
|
Pregnancy Outcome | 1 | 2010 | 2920 | 0.040 |
Why?
|
Genotype | 1 | 2014 | 12982 | 0.040 |
Why?
|
Hepatitis B virus | 1 | 2003 | 529 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2009 | 2650 | 0.040 |
Why?
|
Intestine, Small | 2 | 2019 | 1205 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9180 | 0.040 |
Why?
|
Food Contamination | 1 | 2020 | 191 | 0.040 |
Why?
|
Alcoholism | 1 | 1990 | 1973 | 0.040 |
Why?
|
Health Services Research | 2 | 2017 | 1811 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2015 | 13446 | 0.040 |
Why?
|
Consensus | 2 | 2022 | 3122 | 0.040 |
Why?
|
Animals | 5 | 2021 | 168388 | 0.040 |
Why?
|
Blood Glucose | 1 | 2013 | 6389 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2691 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6473 | 0.040 |
Why?
|
Disclosure | 2 | 2014 | 748 | 0.040 |
Why?
|
Anorexia Nervosa | 1 | 2007 | 1361 | 0.040 |
Why?
|
Leadership | 1 | 2007 | 1385 | 0.040 |
Why?
|
Child, Preschool | 3 | 2018 | 42251 | 0.040 |
Why?
|
Hepatitis B | 1 | 2003 | 707 | 0.040 |
Why?
|
Chronic Disease | 1 | 2012 | 9319 | 0.040 |
Why?
|
Uncertainty | 1 | 2022 | 754 | 0.040 |
Why?
|
Research Design | 1 | 2012 | 6178 | 0.030 |
Why?
|
Gases | 1 | 2017 | 204 | 0.030 |
Why?
|
Bacterial Load | 1 | 2017 | 151 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2009 | 3728 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2021 | 2217 | 0.030 |
Why?
|
Gastroscopy | 1 | 2017 | 210 | 0.030 |
Why?
|
Glucocorticoids | 2 | 2019 | 2163 | 0.030 |
Why?
|
Immunoassay | 1 | 2019 | 746 | 0.030 |
Why?
|
Hydrolysis | 1 | 2017 | 665 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5841 | 0.030 |
Why?
|
Hospitals | 1 | 2009 | 3878 | 0.030 |
Why?
|
Folic Acid | 1 | 2022 | 1320 | 0.030 |
Why?
|
Hookworm Infections | 1 | 2015 | 17 | 0.030 |
Why?
|
Illinois | 1 | 2015 | 120 | 0.030 |
Why?
|
Sequence Homology | 1 | 2015 | 196 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6839 | 0.030 |
Why?
|
Mass Screening | 1 | 2011 | 5428 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2019 | 462 | 0.030 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2019 | 464 | 0.030 |
Why?
|
Parotid Gland | 1 | 2015 | 175 | 0.030 |
Why?
|
ROC Curve | 2 | 2015 | 3572 | 0.030 |
Why?
|
Primary Health Care | 1 | 2011 | 4685 | 0.030 |
Why?
|
Immunity, Innate | 2 | 2019 | 3060 | 0.030 |
Why?
|
Hypertension | 1 | 2014 | 8539 | 0.030 |
Why?
|
Canada | 1 | 2019 | 2120 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 778 | 0.030 |
Why?
|
Enterocytes | 1 | 2015 | 220 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1537 | 0.030 |
Why?
|
Pathology, Clinical | 1 | 2017 | 375 | 0.030 |
Why?
|
Cross Reactions | 1 | 2015 | 818 | 0.030 |
Why?
|
Antibody Specificity | 1 | 2015 | 1060 | 0.030 |
Why?
|
Substance-Related Disorders | 1 | 1990 | 4419 | 0.030 |
Why?
|
Hordeum | 1 | 2012 | 18 | 0.030 |
Why?
|
Public Health Practice | 1 | 2015 | 219 | 0.030 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2003 | 1405 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2017 | 1037 | 0.030 |
Why?
|
U937 Cells | 1 | 2012 | 261 | 0.030 |
Why?
|
Access to Information | 1 | 2015 | 316 | 0.030 |
Why?
|
Dermatitis Herpetiformis | 1 | 2012 | 24 | 0.030 |
Why?
|
Learning | 2 | 2015 | 1740 | 0.020 |
Why?
|
Organizational Case Studies | 1 | 2013 | 301 | 0.020 |
Why?
|
Diet | 1 | 2010 | 8074 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 415 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2012 | 915 | 0.020 |
Why?
|
Hematocrit | 1 | 2013 | 625 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1139 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2017 | 1192 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2015 | 17640 | 0.020 |
Why?
|
Self Efficacy | 1 | 2015 | 637 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2016 | 1184 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4013 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2412 | 0.020 |
Why?
|
Nutritional Support | 1 | 2012 | 172 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2014 | 991 | 0.020 |
Why?
|
Metagenomics | 1 | 2014 | 467 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2015 | 1698 | 0.020 |
Why?
|
Heart Failure | 1 | 2014 | 11672 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2358 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1648 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2015 | 3076 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1403 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13333 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2015 | 2075 | 0.020 |
Why?
|
Epitopes | 1 | 2015 | 2504 | 0.020 |
Why?
|
Intestines | 1 | 2018 | 1909 | 0.020 |
Why?
|
Incidental Findings | 1 | 2014 | 697 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 587 | 0.020 |
Why?
|
Pregnancy | 1 | 2010 | 29858 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2012 | 2749 | 0.020 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2012 | 586 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2578 | 0.020 |
Why?
|
Colitis | 1 | 2016 | 1231 | 0.020 |
Why?
|
Patient Admission | 1 | 2015 | 1367 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4371 | 0.020 |
Why?
|
Malpractice | 1 | 2013 | 556 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2003 | 4236 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22158 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2013 | 934 | 0.020 |
Why?
|
Seasons | 1 | 2012 | 1519 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6309 | 0.020 |
Why?
|
Program Development | 1 | 2013 | 1298 | 0.020 |
Why?
|
Vaccines | 1 | 2015 | 837 | 0.020 |
Why?
|
Faculty | 1 | 2009 | 383 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2011 | 1870 | 0.020 |
Why?
|
Feedback | 1 | 2009 | 791 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2013 | 1265 | 0.020 |
Why?
|
Family | 1 | 2016 | 3197 | 0.020 |
Why?
|
Endoscopy | 1 | 2015 | 1851 | 0.020 |
Why?
|
Esophageal Neoplasms | 1 | 2015 | 1647 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1504 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12666 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 15879 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2811 | 0.010 |
Why?
|
Infant | 2 | 2018 | 36202 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4280 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2015 | 9534 | 0.010 |
Why?
|
Headache | 1 | 2011 | 1256 | 0.010 |
Why?
|
Personal Satisfaction | 1 | 2007 | 642 | 0.010 |
Why?
|
Patient Discharge | 1 | 2015 | 3438 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3577 | 0.010 |
Why?
|
Mentors | 1 | 2007 | 660 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2523 | 0.010 |
Why?
|
Mice | 2 | 2021 | 81474 | 0.010 |
Why?
|
Cytokines | 1 | 2015 | 7390 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10203 | 0.010 |
Why?
|
Calcium | 1 | 2012 | 5726 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15599 | 0.010 |
Why?
|
Vitamin D | 1 | 2012 | 3304 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2003 | 1833 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2003 | 856 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2012 | 14409 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12710 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9468 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18234 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2003 | 21009 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 1990 | 2160 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 22154 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23427 | 0.010 |
Why?
|
Liver | 1 | 2003 | 7531 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2003 | 9275 | 0.000 |
Why?
|